Raj Singh, MD (@raj_singh_md) 's Twitter Profile
Raj Singh, MD

@raj_singh_md

Assistant Professor #RadOnc⚡️@OSUCCC_James 🌰 | @VCURadOncRes '23, @MUSOMWV '18 , @DukeU ‘14| #oligomets, #SABR, #SRS, #btsm, #lcsm, #pedonc |

ID: 1028768217320316932

calendar_today12-08-2018 22:20:31

3,3K Tweet

1,1K Takipçi

565 Takip Edilen

Benjamin Rich (@benrichmd) 's Twitter Profile Photo

🧠 Brain Tumor physicians (Neuro Onc, Med Onc, Rad Onc, Nsgy): Help us assess IDHm glioma practice patterns by completing a 5–7 min anonymous survey. Enter to win one of two $50 Amazon gift cards. 👉 [Survey link] forms.gle/j9zy8vX38ha2qQ…

Sameer Keole (@sameerkeolemd) 's Twitter Profile Photo

Private practice is in trouble The data is clear. The trends are concerning. This is #radonc can do about it. #radonc is proposing ROCR (S. 1031/H.R. 2120) which would immediate stabilize the field, especially the private practices. 1/2

VCU Radiation Oncology Residency (@vcuradoncres) 's Twitter Profile Photo

A big congratulations to our star PGY5 residents Amanda Stark, MD and Joe Wilding, MD CPA for passing their clinic boards! We also recently celebrated their graduation and are excited for them to start as faculty this summer! 🤩🥳

A big congratulations to our star PGY5 residents <a href="/AmandaStarkMD/">Amanda Stark, MD</a> and <a href="/JoeWildingMD/">Joe Wilding, MD CPA</a> for passing their clinic boards! We also recently celebrated their graduation and are excited for them to start as faculty this summer! 🤩🥳
Mark Storey (@protonstorey) 's Twitter Profile Photo

Latest article: PSA screening: So much room for improvement in recommendations to screen and so many opportunities to improve downstream management to limit over-treatment.

Latest article: PSA screening: So much room for improvement in recommendations to screen and so many opportunities to improve downstream management to limit over-treatment.
Matt Spraker (@sprakermdphd) 's Twitter Profile Photo

Immunotherapy has been a boon for our patients with gynecologic cancers. But so has radiotherapy. For >100 years. Come on Merck 😭

Immunotherapy has been a boon for our patients with gynecologic cancers. 

But so has radiotherapy. 

For &gt;100 years. 

Come on <a href="/Merck/">Merck</a> 😭
Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

FDA approves taletrectinib for #ROS1 NSCLC based on TRUST I and TRUST II trials showing 1L RR 85-90% with 63-72% of responses lasting ≥12 months and post TKI, RR 52-62%. Taletrectinib has selectivity over TrkB so should have less neurotoxicity. fda.gov/drugs/resource…

The James (@osuccc_james) 's Twitter Profile Photo

Christian Rolfo, MD, PhD, explains why oncology professionals choose The James to help create a cancer-free world through groundbreaking care and research.

Raj Singh, MD (@raj_singh_md) 's Twitter Profile Photo

Graduation time for our amazing medical and physics residents and also our CNS/Peds fellow! You all are going to do amazing things in your careers and looking forward to seeing what’s to come for you all! ⁦Congrats! ⁦OhioStateRadOnc⁩ ⁦Rituraj Upadhyay, MDRaju Raval, MD DPhil

Graduation time for our amazing medical and physics residents and also our CNS/Peds fellow! You all are going to do amazing things in your careers and looking forward to seeing what’s to come for you all! ⁦Congrats! ⁦<a href="/OhioStateRadOnc/">OhioStateRadOnc</a>⁩ ⁦<a href="/aiims2738/">Rituraj Upadhyay, MD</a> ⁦<a href="/DrRajuRaval/">Raju Raval, MD DPhil</a>
ARRO (@arro_org) 's Twitter Profile Photo

Cover Letter and CV Webinar! Upcoming webinar w/ Nicholas Zaorsky, MD, MS, and Chris Corso, MD, PhD, on writing cover letters and CVs for jobs, promotions and beyond! Have a question you want answered? Let us know here: magnetmail1.net/link.cfm?r=ZBB…~~

Neil D. Gross, MD, FACS (@drneilgross) 's Twitter Profile Photo

The standard of care has finally changed for patients with resectable head and neck #cancer!! Congratulations Ravi Uppaluri, MDPhD and all the #KN-689 investigators. fda.gov/drugs/resource…

Melissa Barber (@mellyb_7) 's Twitter Profile Photo

2 months until SIGA 2025!! ✅Speakers confirmed ✅Registrations open ✅Program released today Full details: sigastereotactic.com/workshop2025/ Register now to use FY24/25 CME

2 months until SIGA 2025!!

✅Speakers confirmed
✅Registrations open 
✅Program released today 

Full details:
sigastereotactic.com/workshop2025/

Register now to use FY24/25 CME
Joshua D. Palmer, MD (@joshuapalmermd) 's Twitter Profile Photo

Great work from our Pediatric team showing excellent outcomes with SBRT for osteosarcoma metastasis with LC 88%. All local failures were BED <48. Sujith Baliga Raj Singh, MD OhioStateRadOnc pubmed.ncbi.nlm.nih.gov/40509558/

the Radiosurgery Society (@the_rss) 's Twitter Profile Photo

Don't miss this FREE #RSSwebinar "SBRT for Non-Spine Bone Metastases: Evidence & Technical Pointers" on June 26 at 1 PM ET featuring Drs. Tim Nguyen and Quynh-Nhu Nguyen, moderated by Winston Vuong. Register now at therss.org/education/webi…

Don't miss this FREE #RSSwebinar "SBRT for Non-Spine Bone Metastases: Evidence &amp; Technical Pointers" on June 26 at 1 PM ET featuring Drs. <a href="/TimkWin/">Tim Nguyen</a> and Quynh-Nhu Nguyen, moderated by <a href="/WinstonVuong/">Winston Vuong</a>.  Register now at therss.org/education/webi…
Amir Safavi (@safaviaa) 's Twitter Profile Photo

Led by Drs. Zakeri & Nancy Lee, we report early Memorial Sloan Kettering Radiation Oncology exp w/ 40 Gy ENI + CCRT for larynx, HPX, p16- OPX + CUP, 97.3% platinum, no uninvolved 1B+5 ☑️73 pts, f/u 23 months ✅no solitary elective failures, all LRF include 70 Gy failures ✅good QoL 👉 shorturl.at/CKA6W

Led by Drs. Zakeri &amp; <a href="/imrtlee/">Nancy Lee</a>, we report early <a href="/MSK_RadOnc/">Memorial Sloan Kettering Radiation Oncology</a> exp w/ 40 Gy ENI + CCRT for larynx, HPX, p16- OPX + CUP, 97.3% platinum, no uninvolved 1B+5

☑️73 pts, f/u 23 months
✅no solitary elective failures, all LRF include 70 Gy failures
✅good QoL

👉 shorturl.at/CKA6W
Jason Sheehan (@jasonpsheehan) 's Twitter Profile Photo

Dr. Kotecha and his team published a new study in IJROBP on RICE after proton therapy. The RICE lesions are denoted by the yellow arrows.

Dr. Kotecha and his team published a new study in IJROBP on RICE after proton therapy.  The RICE lesions are denoted by the yellow arrows.
Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

Important awareness piece by BBC News (UK) reminding us that lung cancer is on the rise in people who have never smoked. These are different types of lung cancer and we’re still learning why they occur: radon, pollution, unknown. All of us are at risk. bbc.com/future/article…